A proof-of-concept study with the tyrosine kinase inhibitor nilotinib in spondyloarthritis
Crossref DOI link: https://doi.org/10.1186/s12967-016-1050-2
Published Online: 2016-10-27
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Paramarta, Jacqueline E.
Turina, Maureen C.
Noordenbos, Troy
Heijda, Tanja F.
Blijdorp, Iris C.
Yeremenko, Nataliya
Baeten, Dominique